Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Inhibikase Therapeutics
Inhibikase Therapeutics is a therapeutic Vaccines founded in 2008 by Daniel Kalman.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
B2X
B2B
Board of Directors
Milton H. Werner
0
Business Model
Commerce
CAGE Code
57Q52
0
CEO
Milton H. Werner
0
CIK Number
1,750,149
0
Legal Name
Inhibikase Therapeutics, Inc.
Company Operating Status
Active
Contact Page URL
inhibikase.com/contact
Country
United States
Crunchbase URL
crunchbase.com/organiz...hibikase
DUNS Number
828325899
0
Email Address
info@inhibikase.com
0
Facebook URL
@Inhibikase
Founded Date
2008
Founder
Daniel Kalman
Full Address
3350 Riverwood Parkway Suite 1900 Atlanta, GA 30339
0
One Marina Park Drive Suite 1410 Boston, MA 02210
0
Industry
Engineering
Vaccine
Biomedical engineering
Biopharmaceutical
Technology
Healthcare
Biology
Biotechnology
Investors
The Michael J. Fox Foundation For Parkinson'S Research
Latest Funding Round Date
March 9, 2017
Latest Funding Type
Grant (money)
LinkedIn URL
@company/inhibikase-therapeutics
Location
Atlanta
0
Boston
0
United States
Number of Employees (Ranges)
1 – 10
Patents Assigned (Count)
7
Phone Number
+16783923419
0
Place of Incorporation
Delaware
0
SIC Code
2,836
0
Exchange
Nasdaq
0
Stock Symbol
IKT
0
Ticker Symbol
IKT
Total Funding Amount (USD)
433,000
Twitter URL
@inhibikase
Official Website
inhibikase.com
Find more companies like Inhibikase Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE